Influence of sow vaccination against Mycoplasma hyopneumoniae on the protection of piglets through vaccination;Einfluss der Vakzination von Sauen gegen Mycoplasma Hyopneumoniae auf den Impfschutz der Ferkel

Tierarztliche Praxis Ausgabe G: Grosstiere - Nutztiere

Volumn 35, Issue 4, 2007, Pages 283-288

  Strauss, C ^a   Palzer, A ^a   Heinritzi, K ^a   Ritzmann, M ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Maternal antibodies; Mycoplasma hyopneumoniae; Swine; Vaccination

Indexed keywords

ANIMALIA; MYCOPLASMA; MYCOPLASMA HYOPNEUMONIAE; SUIDAE;

EID: 34548640110     PISSN: 14341220     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1621432     Document Type: Article

References (39)

1. Andreasen M, Nielsen JP, Baekbo P. Colostral antibodies and duration of maternal immunity: Mycoplasma hyopneumoniae and Actinobacillus pleuropneumoniae serotype 2. Proc. 16th Congress Int Pig Vet Soc, Melbourne 2000; 446.
2. Bertschinger HU, Keller H, Löhrer A, Wegmann W. Der zeitliche Verlauf der experimentellen Enzootischen Pneumonie beim SPF-Schwein. Schweiz Arch Tierheilk 1972; 114: 107-116.
3. Clark LK. Control or eradication of mycoplasmal pneumonia of swine. 28th Ann. Meeting American Assoc of Swine Pract, Quebec City 1997; 403-406.
4. Diaz EF, Chevez JC, Angulo JR. Using sow vaccination Mycoplasma protocols for the control of Mycoplasma hyopneumoniae, Proc 19th Congress Int Pig Vet Soc, Kopenhagen 2006; 136.
5. Grosse Beilage E. Klinische und serologische Verlaufsuntersuchungen zu Prävalenz, Inzidenz und Interaktion viraler und bakterieller Infektionen des Respirationstraktes von Mastschweinen. Habilitationsschrift, Tierärztl Hochschule Hannover 1999.
6. Grosse Beilage E, Pabst T, Spergser J, Diagnostik der Enzootischen Pneumonie in Schweineherden nach Impfung gegen Mycoplasma hyopneumoniae. Teil 2: Verlaufsuntersuchungen zum Nachweis von M. hyopneumoniae mit PCR. Tierärztl Prax 2005; 33 (G): 313-318.
7. Grosse Beilage E, Schreiber A, Pabst T. Diagnostik der Enzootischen Pneumonie in Schweineherden nach Impfung gegen Mycoplasma hyopneumoniae. Teil 1: Seroreaktionen von Schweinen auf verschiedene Impfschemata. Tierärztl Prax 2005; 33 (G): 239-245.
8. Holyake PK, Callinan APL. How effective is Mycoplasma hyopneumoniae vaccination in pigs less than three weeks of age. J Swine Health Prod 2006; 14: 189-195.
9. Jayappa H, Davis R, Rapp-Gabrielson VJ, Wasmoen TL, Thacker E, Thacker B. Evaluation of the efficacy of Mycoplasma hyopneumoniae baeterin following immunization of young pigs in the presence of varying levels of maternal antibodies. J Am Vet Med Assoc 2001; 238: 237-240.
10. Jericho KWF. Pathogenesis of Mycoplasma pneumonia of swine. Can J Vet Res 1986; 50: 136-137.
11. Joisel F, Castaing J, Coudure R, Sansot B, Longo S, Hérin JB. Effects of Mycoplasma vaccination with Hyoresp® on economical and production parameters in swine. Proc. 17th Congress Int Pig Vet Soc Ames, Iowa 2002; 344.
12. Jolie R, Sabbadini L, Aubin ST, Runnels P. Evaluation of a 25-week duration of immunity of Respisure One in Mycoplasma hyopneumoniae serological and seropositive pigs. Proc. 18th Congress Int Pig Vet Soc, Hamburg 2004; 395.
13. Kobisch M, Quillien L, Wróbelewski JPH. The Mycoplasma hyopneumoniae plasma membrane as a vaccine against porcine enzootic pneumonia. Annales de L'Institut Pasteur, Immunology 1987; 138: 693-705.
14. Klobasa F, Butler JE. Absolute and relative concentrations of immunglobins G, M and A, and albumin in the lacteal secretion of sows of different lactation numbers. Am J Vet Res 1987; 48: 176-182.
15. Kristensen CS, Andreasen M, Ersboll AK, Nielsen JP. Vaccination of sows with Porcilis® APP, Stellamune® Mycoplasma and Atrinord® Do. Proc 17th Congress Int Pig Vet Soc, Ames, Iowa, 2002; Vol. 2; 102.
16. Kuhn MJ, Thacker BJ, Hawkins PA, Waters WR, Thacker EL. Evaluation of the mode action of RespiSure® Mycoplasma hyopneumoniae bacterin. Proc 31st Ann Meeting Am Assoc Swine Pract, Indianapolis, 2000; 123.
17. Kyriakis SC, Alexopoulos C, Vlemmas J, Sarris K, Lekkas S, Koutsoviti-Papadopoulou M, Saoulidis K. Field study on the efficacy of two different vaccination schedules with HYORESP® in a Mycoplasma hyopneumoniae-infected commercial pig unit. J Vet Med B 2001; 48: 675-684.
18. Lillie K, Ritzmann M, Erber M, Heinritzi K. Untersuchungen zur Wirkung und Verträglichkeit eines inaktivierten Mycoplasma hyopneumoniae- One-Shot-Impfstoffes zu unterschiedlichen Vakzinationszeitpunkten -1. Mitteilung. Prakt Tierarzt 2006; 87: 548-552.
19. Madec F, Kobisch M. Bilan lésionnel des poumons de porcs charcutiers á l'abattoir. Journées rech Porcine en France 1982; 14: 405-412.
20. Maes D, Deyluyker H, Verdonck M, Castryck F, Miry C, Vrijens B, de Kruif A. Herd factors associated with the seroprevalences of four major respiratory pathogens in slaughter pigs from farrow-to-finish pig herds. Vet Res 2000; 31: 313-327.
21. Martelli P, Terreni M, Guazzetti S, Cavirani S. Antibody response to Mycoplasma hyopneumoniae infection in vaccinated pigs with or without maternal antibody induced by sow vaccination. J Vet Med B 2006; 53: 229-233.
22. Molitor T, Bandrick M, Pieters M, Pijoan C. Maternal transfer of immunity: role in Mycoplasma hyopneumoniae. Proc Allen D Leman Conf 2006; 75-78.
23. Morris TR, Gardner IA, Hietala SK, Carpenter TE, Anderson RJ, Parker KM. Persistance of passively acquired antibodies to Mycoplasma hyopneumoniae in a swine herd. Prev Vet Med 1994; 21: 29-41.
24. Noyes EP, Feeney DA, Pijoan C. Comparison of the effect of pneumonia detected during lifetime with pneumonia detected at slaughter on growth of swine. J Am Vet Assoc 1990; 197: 1025-1029.
25. Palzer A, Ritzmann M, Wolf G, Heinritzi K. Erregernachweis aus bronchoalveolärer Lavage bei Schweinen mit Atemwegserkrankungen, Tierärztl Umsch 2005; 60: 550-556.
26. Radeloff I. Untersuchungen zur Wirksamkeit eines inaktivierten Mycoplasma hyopneumoniae Impfstoffes (Stellamune®, Mycoplasma) bei unterschiedlichen Vakzinationszeitpunkten. Diss med vet, München 1997.
27. Rautianen E, Wallgren P. Aspects of the transmission of protection against Mycoplasma hyopneumoniae from sow to offspring. J Vet Med B 2001; 48: 55-65.
28. Ristow LE, Silva LGC, Fóscolo CB, Silva AF. Comparison of Mycoplasma hyopneumoniae vaccines and the influence of maternal antibodies. Proc. 17th Congress Int Pig Vet Soc, Ames, Iowa, 2002; Vol. 2; 333.
29. Ruiz A, Utera V, Pijoan C. Effect of Mycoplasma hyopneumoniae sow vaccination on piglet colonization at weaning. J Swine Health Prod 2003; 11: 131-135.
30. Selbitz HJ. Mykoplasmeninfektion der Schweine. In: Medizinische Mikrobiologie, Infektions- und Seuchenlehre, 7. Aufl. Rolle M, Mayr A, Hrsg. Stuttgart: Enke 2002; 567-569.
31. Simon X, Sitjar M, Noyes E, Alcaide C, Fernandez de Aragon J, Pijoan C. Relationship between lifetime pneumonia lesions, slaughter volumetric and superficial lung lesions and productive parameters in pigs. Proc. 13th Congress Int Pig Vet Soc, Bangkok, 1994; 132.
32. Sitjar M, Noyes E, Moreso JM, Fernandez de Aragon J, Pijoan C. Relationship between respiratory pathogen seroconversion and lung lesions in pigs. Proc 13th Congress Int Pig Vet Soc, Bangkok, 1994; 133.
33. Sorensen V, Barfod K, Feld NC, Vraa-Anderson L. Application of enzyme-linked immunosorbent assay for the surveillance of Mycoplasma hyopneumoniae infection in pigs. Revue scientifique et technique 1993; 12: 592-604.
34. Surprenant C. Mycoplasma hyopneumoniae: serologic interpretation of swine herd profiles. Proc 32nd Ann Meeting Am Assoc Swine Pract, Nashville, 2001; 477.
35. Thacker B, Thacker E, Halbur P, Minion F, Young T, Erickson B, Thanawongnuwech T. The influence of maternally-derived antibodies on Mycoplasma hyopneumoniae infection. Proc 16th Congress Int Pig Vet Soc, Melbourne, 2000; 454.
36. Thacker E, Thacker B, Kuhn M, Hawkins P, Waters R. Evaluation of local and systemic immune responses induced by intramuscular injection of a Mycoplasma hyopneumoniae baeterin to pigs. Am J Vet Res 2000; 31: 1384-1389.
37. Thacker B, Thacker E. Influence of maternally derived antibodies on the efficacy of Mycoplasma hyopneumoniae bacterin. Proc 32nd Ann Meeting Am Assoc Swine Pract, Nashville, 2001; 513-516.
38. Thacker B, Wegner M, Erlandson K, Maxwell K, Thompson J, Thacker E. Influence of maternal immunity on mycoplasma vaccine Respisure One efficacy. Proc 17th Congress Int Pig Vet Soc, Ames, Iowa, 2002; Vol. 2; 307.
39. Wallgren P, Löffsted M, Heldmer E. Strategic vaccination against Mycoplasma hyopneumoniae avoid marketing contagious animals from multiplying herds, Proc 15th Congress Int Pig Vet Soc, Birmingham, 1998; 149.